| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/28/2001 | CN1288749A Medicated sanitary article for treating gynopathy and its preparation |
| 03/28/2001 | CN1288747A Composite medicine containing dihydromyricetrin |
| 03/28/2001 | CN1288730A Slight-purgitive composition |
| 03/28/2001 | CN1288729A Freeze dried lentinan holoside powder injecta and its preparation |
| 03/28/2001 | CN1288727A Composite medicine for rhinitis and its application |
| 03/28/2001 | CN1288726A Medicine preparation containing ferrous saccharin |
| 03/28/2001 | CN1288725A Preparation of serial veterinary injecta products |
| 03/28/2001 | CN1288688A Composition containing original flower pigment and vitamin B6 derivative or its salt |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/28/2001 | CN1063755C Oligomeric deoxynucleotide of vascular endothelial cell growth factor |
| 03/28/2001 | CN1063753C Method for preparing platinum compound |
| 03/28/2001 | CN1063749C Azabicyclic esters of carbamino acids used in therapy |
| 03/28/2001 | CN1063747C Quinotone and naphthyridonecarboxylic acid derivatives |
| 03/28/2001 | CN1063744C 15-deoxyspergulin analogs, their method of preparation and their use in therapeutics |
| 03/28/2001 | CN1063666C Oil-state fine medicinal powder preparation for treating carbuncle, sore and preparation method thereof |
| 03/28/2001 | CN1063645C Compound Chinese and western medicinal composition for treating 'zhongxiao' type diabetes |
| 03/28/2001 | CN1063644C Compound Chinese and western medicinal composition for treating diabetes of 'shangxiao' type |
| 03/28/2001 | CN1063631C 乳酸软膏 Lactic acid ointment |
| 03/28/2001 | CN1063627C Composition for regulating skin wrinkles and/or skin atrophy |
| 03/28/2001 | CA2283975A1 Combined therapies for atherosclerosis treatment |
| 03/27/2001 | USRE37116 Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders |
| 03/27/2001 | US6208719 Method and apparatus for telecommunications having automatic network adaptations and silent mode operations |
| 03/27/2001 | US6207863 Synthesis of haloformimine compounds |
| 03/27/2001 | US6207856 Therapeutic compositions |
| 03/27/2001 | US6207855 Stable no-delivering compounds |
| 03/27/2001 | US6207852 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 03/27/2001 | US6207842 Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives |
| 03/27/2001 | US6207836 Indolin-2-one derivatives |
| 03/27/2001 | US6207832 Camptothecin analogs and methods of preparation thereof |
| 03/27/2001 | US6207829 Cyclization of a corresponding pyrazole compound |
| 03/27/2001 | US6207820 Solid phase synthesis by linking acceptor monosaccharide to support forming carboxylate or carboxyamide linkage, covalently linking donor saccharide by o-glycosidic linkage, coupling lipophosphoglycerate mimetic, cleaving from support |
| 03/27/2001 | US6207816 High affinity oligonucleotide ligands to growth factors |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207716 Non-steroidal ligands for the estrogen receptor |
| 03/27/2001 | US6207714 Orally administering (-)-hydroxycitric acid for treating or ameliorating diabetes or insulin resistance by lowering elevated blood sugar levels |
| 03/27/2001 | US6207713 Orally administering to the body adelivery vehicle for nitric oxide releasing substance selected from l-arginine, l-arginine salts or derivatives for increasing local blood flow |
| 03/27/2001 | US6207710 Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 03/27/2001 | US6207709 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds having kynurenine-3-hydroxy base inhibitory activity |
| 03/27/2001 | US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis, |
| 03/27/2001 | US6207706 Use of COMT inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 03/27/2001 | US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma |
| 03/27/2001 | US6207702 Method for reducing postprandial oxidative stress using cocoa procyanidins |
| 03/27/2001 | US6207701 Urokinase inhibitors |
| 03/27/2001 | US6207700 Aministering carboxylic acid secondary amide derivative containing indole system which is selective for inhibition of cyclooxygenase-2 for cancer therapy in warm blooded vertebrate animal |
| 03/27/2001 | US6207699 Reducing weight of a human, comprising administering synergistic combination with of l-5-hydroxytryptophan, carbidopa, and of pindolol |
| 03/27/2001 | US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection |
| 03/27/2001 | US6207697 Amidinyl-substituted rings; anticoagulants; thromboembolic disorders; antiischemic and antiinflammatory agents; strokes; serine protease inhibitors |
| 03/27/2001 | US6207696 Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine |
| 03/27/2001 | US6207694 Pharmaceutical compositions and methods for managing scalp conditions |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207691 Fungicidal active compound combinations |
| 03/27/2001 | US6207690 Treating tumor by administering therapeutically effective amount of triglitazone compound |
| 03/27/2001 | US6207688 Treating multi-drug resistant, non-nucleoside reverse transcriptase resistant, and therapy naive hiv infection by administering phenethyl-thiourea derivative |
| 03/27/2001 | US6207687 Substituted imidazoles having cytokine inhibitory activity |
| 03/27/2001 | US6207686 Endothelin antagonists |
| 03/27/2001 | US6207685 Inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals by administering 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in pure racemic, diastereoisomeric or enantiomeric form |
| 03/27/2001 | US6207684 Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use |
| 03/27/2001 | US6207683 Benzocycloheptathiophene compounds |
| 03/27/2001 | US6207681 Methods and compositions for treating urinary incontinence using enantiomerically enriched (R)-trihexyphenidyl |
| 03/27/2001 | US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics |
| 03/27/2001 | US6207678 Used for treating inflammatory disease such as arthritis, psoriasis, asthma or inflammatory bowel disease, central nervous system disorder such as anxiety, depression, dementia or psychosis, gastrointestinal disorders |
| 03/27/2001 | US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia |
| 03/27/2001 | US6207675 For prophylaxis and therapy of diseases in which are involved viruses of the herpes family and/or cytokines in particular tumor nercosis factor-alpha |
| 03/27/2001 | US6207674 Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| 03/27/2001 | US6207672 Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids |
| 03/27/2001 | US6207670 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 03/27/2001 | US6207669 In treatment of cancer and psoriasis |
| 03/27/2001 | US6207667 1,3 diazines with platelet-derived growth factor receptor inhibitory activity |
| 03/27/2001 | US6207666 Treating precancerous lesions by administering 4-phenylphthalazine derivative |
| 03/27/2001 | US6207665 To treat inflammatory disorders in humans |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/27/2001 | US6207661 Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| 03/27/2001 | US6207660 Texaphyrin conjugates and uses thereof |
| 03/27/2001 | US6207659 Administering therapeutically effective amount of 17.alpha.-dihydroequilenin or mammalian metabolic conjugate to mammal for preventing abnormal cardiac rhythms induced by ischemia |
| 03/27/2001 | US6207658 Preservation of tissue during removal storage and implantation |
| 03/27/2001 | US6207657 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them |
| 03/27/2001 | US6207656 Treating neurodegenerative diseases or disorders by administering low calcemic vitamin d analog compound |
| 03/27/2001 | US6207654 Intravenously administering hydroxyethyl starch or dextran or their mixture and interferon or interleukins for treating human to prevent leakage of macromolecules from capillary endothelial junctions due to side effects of cancer, infection |
| 03/27/2001 | US6207653 Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 03/27/2001 | US6207652 Inducing apoptosis by using sulfated-fucose-containing polysaccharides and/or degradation products thereof as the active ingredient |
| 03/27/2001 | US6207651 Method for treatment and prevention of deficiencies of vitamins B12, folic acid, and B6 |
| 03/27/2001 | US6207649 Nucleoside analogs and uses in treating disease |
| 03/27/2001 | US6207648 Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207638 For enhancing and extending post meal satiety by stimulating cholecystokinin levels in a calorically efficient manner for reducing weight, comprising protein consisting of casein, whey and soy, glycomacropeptide, long chain fatty acids, fibers |
| 03/27/2001 | US6207596 Disposable premoistened wipe containing an antimicrobial protease inhibitor |
| 03/27/2001 | US6207457 Targeted nucleotide sequence delivery and integration system |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207438 Method for preparing a product in particular for preventing and curing skin diseases, and resulting product |
| 03/27/2001 | US6207428 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of streptomyces sp. P 6621 FERM P 2804 |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207403 Kinesin motor modulators derived from the marine sponge Adocia |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207198 Omeprazole core comressed together with inert nuclei coated with a polymeric intermediatel layer overcoated with an enteric layer; stabilization |
| 03/27/2001 | US6207197 Microsphere comprising a drug-containing inner core, water insoluble polymeric rate controlling layer, and a bioadhesive outer layer of cationic polymer; treatment of helicobacter pylori |
| 03/27/2001 | US6207195 Sodium 4-phenylbutyrate in solid nanosphere formed by coacervation of a polycation, i.e., a protein and a polyanion, i.e., a nucleic acid; treatment of cystic fibrosis |